Phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H vs EU-Neulasta ® in the prophylactic treatment of chemotherapy-induced neutropenia

European Journal of Cancer
February 1, 2017
Cited by 2

Abstract


Related Papers

No related papers found

Powered by citation graph analysis